SCHEMBL1708018

SCHEMBL1708018

CCOc1nc2cc(F)c(F)cc2n1-c1cccc2c1OC[C@H]2N(C(=O)C(F)(F)F)c1ccc2c(c1)OC[C@H]2CC(=O)OC

nearest known ligand 0.34

Predicted protein targets (top 2)

geneUniProtsupporting neighboursconfidence
FFAR1 O14842 19/20 0.34
LMNA P02545 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL10010224 0.94 FFAR1 (0.38) FFAR1
SCHEMBL1708142 0.93 FFAR1 (0.33) FFAR1LMNA
SCHEMBL1708591 0.93 FFAR1 (0.33) FFAR1LMNA
SCHEMBL1708330 0.92 LMNA (0.35) FFAR1LMNA
SCHEMBL1708383 0.92 LMNA (0.35) FFAR1LMNA
SCHEMBL1708629 0.91 FFAR1 (0.35) FFAR1LMNA
SCHEMBL1708379 0.90 FFAR1 (0.33) FFAR1LMNA
SCHEMBL1708603 0.90 FFAR1 (0.35) FFAR1LMNA
SCHEMBL10011276 0.86 FFAR1 (0.37) FFAR1
SCHEMBL10009505 0.86 FFAR1 (0.37) FFAR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2440541-A1 NOVEL FUSED CYCLIC COMPOUND AND USE THEREOF Takeda Pharmaceutical Company Limited (JP) 2012-04-18 EP disclosed
WO-2010143733-A1 NOVEL FUSED CYCLIC COMPOUND AND USE THEREOF TAKEDA PHARMACEUTICAL COMPANY LIMITED (JP) 2010-12-16 WO disclosed